Halozyme Therapeutics, Inc. (0J2O.L)

USD 48.78

(0.12%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.73 Billion 1.84 Billion 1.1 Billion 579.92 Million 565.87 Million 440.24 Million
Total Current Assets 746.42 Million 739.01 Million 926.28 Million 554.76 Million 543.43 Million 427.84 Million
Cash And Short Term Investments 336 Million 362.79 Million 740.92 Million 368.01 Million 421.26 Million 354.52 Million
Cash and Cash Equivalents 118.37 Million 234.19 Million 118.71 Million 147.7 Million 120.17 Million 57.93 Million
Short Term Investments 217.63 Million 128.59 Million 622.2 Million 220.31 Million 301.08 Million 296.59 Million
Net Receivables 234.21 Million 231.07 Million 90.97 Million 97.73 Million 59.44 Million 30 Million
Inventory 127.6 Million 100.12 Million 53.9 Million 60.74 Million 29.35 Million 22.62 Million
Other Current Assets 48.61 Million 45.02 Million 40.48 Million 28.27 Million 33.37 Million 20.69 Million
Total Non-Current Assets 986.84 Million 1.1 Billion 178.14 Million 25.16 Million 22.43 Million 12.39 Million
Net PPE 74.94 Million 75.57 Million 8.79 Million 10.59 Million 10.85 Million 7.46 Million
Good Will And Intangible Assets 889.7 Million 955.7 Million -500 Thousand - - -
Good Will 416.82 Million 409.04 Million - - - -
Intangible Assets 472.87 Million 546.65 Million - - - -
Long-Term Investments - 500 Thousand 500 Thousand 500 Thousand 500 Thousand 500 Thousand
Tax Assets 4.38 Million 44.42 Million 155.43 Million - - -
Other Non Current Assets 17.81 Million 26.3 Million 13.91 Million 14.06 Million 11.08 Million 4.43 Million
Other Assets - - - - - -
Total Liabilities 1.64 Billion 1.67 Billion 907.47 Million 428.87 Million 474.1 Million 191.36 Million
Total Current Liabilities 112.49 Million 130.78 Million 117.14 Million 421.38 Million 85.63 Million 149.36 Million
Account Payables 11.81 Million 17.69 Million 1.54 Million 1.92 Million 6.43 Million 4.07 Million
Tax Payables 963 Thousand - - - - -
Short Term Debt 32.19 Million 13.33 Million 89.41 Million 397.22 Million 19.54 Million 91.5 Million
Deferred Revenue -32.19 Million 3.24 Million 1.74 Million 1.74 Million 4.01 Million 4.24 Million
Other Current Liabilities 100.67 Million 96.51 Million 24.44 Million 20.48 Million 55.64 Million 49.52 Million
Total Non Current Liabilities 1.53 Billion 1.54 Billion 790.32 Million 7.49 Million 388.47 Million 42 Million
Long-Term Debt 1.49 Billion 1.49 Billion 787.25 Million 3.46 Million 383.04 Million 34.87 Million
Deferred Revenue Non Current - 2.25 Million 2.53 Million 4.02 Million 1.24 Million 5 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 37.72 Million 45.9 Million 544 Thousand 3.46 Million 4.18 Million 2.11 Million
Other Liabilities - - - - - -
Total Equity 83.8 Million 169.79 Million 196.95 Million 151.04 Million 91.76 Million 248.88 Million
Stock Holders Equity 83.8 Million 169.79 Million 196.95 Million 151.04 Million 91.76 Million 248.88 Million
Common Stock 127 Thousand 135 Thousand 138 Thousand 135 Thousand 137 Thousand 145 Thousand
Retained Earnings 90.55 Million 143.21 Million -58.91 Million -474.59 Million -603.67 Million -531.43 Million
Accumulated other comprehensive income -9.27 Million -922 Thousand -620 Thousand 22 Thousand 240 Thousand -277 Thousand
Common Stock Equity 83.8 Million 169.79 Million 196.95 Million 151.04 Million 91.76 Million 248.88 Million
Capital Lease Obligation 32.19 Million 34.78 Million 2.82 Million 4.86 Million 6.46 Million -
Total Investments 217.63 Million 128.59 Million 622.2 Million 220.31 Million 301.08 Million 296.59 Million
Total Debt 1.49 Billion 1.5 Billion 876.67 Million 397.22 Million 402.58 Million 126.38 Million
Net Debt 1.38 Billion 1.27 Billion 757.95 Million 249.52 Million 282.4 Million 68.44 Million

Balance Sheet Charts